Screening for latent tuberculosis infection in patients with inflammatory bowel disease: Can interferon-gamma release assays replace the tuberculin skin test?

BACKGROUND/AIMS: Screening for latent tuberculosis infection is mandatory before starting anti-tumor necrosis factor therapy. New assays based on interferon-γ (IFN-γ) release have recently become available and may be more accurate. The aim of this study was to compare QuantiFERON-TB and tuberculin s...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Turk J Gastroenterol
Glavni autori: Cabriada, José Luis, Ruiz-Zorrilla, Rafael, Barrio, Jesús, Atienza, Ramón, Huerta, Alain, Rodríguez-Lago, Iago, Bernal, Antonio, Herrero, César
Format: Artigo
Jezik:Inglês
Izdano: Turkish Society of Gastroenterology 2018
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6284653/
https://ncbi.nlm.nih.gov/pubmed/29755013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/tjg.2018.17162
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items